Hyaluronic acid in the treatment of osteoarthritis of various localization: A review

Cover Page

Cite item

Full Text

Abstract

The article discusses the treatment of osteoarthritis (OA), the prevalence of which is high, and according to some forecasts it will increase by 50% in the next 20 years. The authors emphasize the high comorbidity among patients suffering from OA and high cardiovascular and gastrointestinal risks with frequent use of NSAIDs, the volume of consumption of which is constantly increasing. Discussing recommendations for the treatment of patients with OA, the article focuses on the use of hyaluronic acid (HA) preparations in the treatment of OA. The mechanisms of anti-inflammatory and chondroprotective actions of HA in the joint, its effect on cartilage and synovial membrane are discussed. Attention is drawn to the fact that, despite more than 30 years of experience in the effective use of HA preparations in the treatment of OA, this procedure is still a subject of controversy among international professional communities. The article presents data from meta-analyses and systematic reviews confirming the effectiveness of the use of intra-articular management of HA preparations in OA of various localization (knee joints, hip joints, hand joints). In conclusion, the recommendations of the technical expert group established at the International Symposium on Intra-Articular Treatment are given to determine the criteria for the successful administration of HA in OA of various localizations, as well as predictors of success and non-success of therapy with HA drugs. The experts identified indications, contraindications for intra-articular administration of HA preparations, as well as conditions associated with an increased risk of therapy failure. In conclusion, the authors draw conclusions about the importance of using HA preparations for intra-articular administration for the treatment of OA, starting from the early stages, following the recommendations of experts.

About the authors

Yulia S. Filatova

Yaroslavl State Medical University

Author for correspondence.
Email: y.s.filatova@mail.ru
ORCID iD: 0000-0003-3024-9483

канд. мед. наук, доц. каф. терапии им. проф. Е.Н. Дормидонтова Института последипломного образования

Russian Federation, Yaroslavl

Igor N. Soloviev

Yaroslavl State Medical University

Email: y.s.filatova@mail.ru
ORCID iD: 0000-0002-9347-1551

канд. мед. наук, доц. каф. травматологии и ортопедии

Russian Federation, Yaroslavl

References

  1. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-59. doi: 10.1016/S0140-6736(19)30417-9
  2. Fioravanti A, Tenti S, Cheleschi S. Editorial: Year 2020: New Trends in Pharmacological Treatments for Osteoarthritis. Front Pharmacol. 2022;13:892934. doi: 10.3389/fphar.2022.892934
  3. Alvarez C, Cleveland RJ, Schwartz TA, et al. Comorbid conditions and the transition among states of hip osteoarthritis and symptoms in a community-based study: a multi-state time-to-event model approach. Arthritis Res Ther. 2020;22(1):12. doi: 10.1186/s13075-020-2101-x
  4. Филатова Ю.С., Соловьев И.Н. Тактика ведения пациентов с остеоартритом: взгляд ревматолога и травматолога-ортопеда. Медицинский Совет. 2020;(19):89-97 [Filatova YuS, Solovyov IN. Management tactics for patients with osteoarthritis: a joint view of a rheumatologist and an orthopedic traumatologist. Meditsinskiy sovet = Medical Council. 2020;(19):89-97 (in Russian)]. doi: 10.21518/2079-701X-2020-19-89-97
  5. Филатова Ю.С., Соловьев И.Н. Пациент с остеоартритом коленных суставов: тактика ведения в амбулаторных условиях. Медицинский Совет. 2021;(2):86-93 [Filatova YuS, Solovyov IN. Patients with osteoarthritis of the knee: management in the outpatient setting. Meditsinskiy sovet = Medical Council. 2021;(2):86-93 (in Russian)]. doi: 10.21518/2079-701X-2021-2-86-93
  6. Leyland KM, Gates LS, Sanchez-Santos MT, et al. Knee osteoarthritis and time-to all-cause mortality in six community-based cohorts: an international meta-analysis of individual participant-level data. Aging Clin Exp Res. 2021;33(3):529-45. doi: 10.1007/s40520-020-01762-2
  7. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149-62. doi: 10.1002/acr.24131
  8. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337-50. doi: 10.1016/j.semarthrit.2019.04.008
  9. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578-89. doi: 10.1016/j.joca.2019.06.011
  10. Клинические рекомендации «Гонартроз» (утв. Минздравом России). Режим доступа: https://legalacts.ru/doc/klinicheskie-rekomendatsii-gonartroz-utv-minzdravom-rossii/ Ссылка активна на 05.08.2022 [Klinicheskie rekomendatsii «Gonartroz» (utv. Minzdravom Rossii). Available at: https://legalacts.ru/doc/klinicheskie-rekomendatsii-gonartroz-utv-minzdravom-rossii/ Accessed: 05.08.2022 (in Russian)].
  11. Клинические рекомендации «Коксартроз» (утв. Минздравом России). Режим доступа: https://legalacts.ru/doc/klinicheskie-rekomendatsii-koksartroz-utv-minzdravom-rossii/ Ссылка активна на 05.08.2022 [Klinicheskie rekomendatsii «Koksartroz» (utv. Minzdravom Rossii). Available at: https://legalacts.ru/doc/klinicheskie-rekomendatsii-koksartroz-utv-minzdravom-rossii/ Accessed: 05.08.2022 (in Russian)].
  12. Филатова Ю.С., Ильин М.В., Соловьев И.Н. Остеоартрит: современные возможности терапии. Амбулаторная хирургия. 2022;19(1):60-7 [Filatova YuS, Ilyin MV, Soloviev IN. Osteoarthritis: modern possibilities of therapy. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2022;19(1):60-7 (in Russian)]. doi: 10.21518/1995-1477-2022-19-1-60-67
  13. Sharma L. Osteoarthritis of the Knee. N Engl J Med. 2021;384(1):51-9. doi: 10.1056/NEJMcp1903768
  14. American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. Pain Med. 2009;10(6):1062-83. doi: 10.1111/j.1526-4637.2009.00699.x
  15. Bruyère O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis – from evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(Suppl. 4):S3-11. doi: 10.1016/j.semarthrit.2015.11.010
  16. Cho SK, Choi S, Kim H, et al. COX-2 Inhibitor Use as an Early Treatment Option for Knee Osteoarthritis Patients in Korea: A Population-Based Cross-Sectional Study. J Korean Med Sci. 2022;37(18):e148. doi: 10.3346/jkms.2022.37.e148
  17. Bothner H, Wik O. Rheology of hyaluronate. Acta Otolaryngol. 1987;104(S442):25-30. doi: 10.3109/00016488709102834
  18. Wang C-T, Lin Y-T, Chiang B-L, et al. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthr Cartilage. 2006;14(12):1237-47. doi: 10.1016/j.joca.2006.05.009
  19. Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum. 2002;32(1):10-37. doi: 10.1053/sarh.2002.33720
  20. Yasuda T. Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages. Tohoku J Exp Med. 2010;220(3):229-35. doi: 10.1620/tjem.220.229
  21. Asari A, Miyauchi S, Matsuzaka S, et al. Molecular weight – dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol. 1998;61(2):125-35. doi: 10.1679/aohc.61.125
  22. Sasaki A, Sasaki K, Konttinen YT, et al. Hyaluronate inhibits the interleukin-1beta-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells. Tohoku J Exp Med. 2004;204(2):99-107. doi: 10.1620/tjem.204.99
  23. Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol (Paris). 1974;22(8):731-6.
  24. Nelson AE, Allen KD, Golightly YM, et al. A systematic review of recommendations and guidelines for the management of osteoarthritis: the chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin Arthritis Rheum. 2014;43(6):701-12. doi: 10.1016/j.semarthrit.2013.11.012
  25. Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145-55. doi: 10.1136/ard.2003.011742
  26. National Collaborating Centre for Chronic Conditions (UK). Osteoarthritis: National Clinical Guideline for Care and Management in Adults. London: Royal College of Physicians (UK), 2008.
  27. Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21(9):571-6. doi: 10.5435/JAAOS-21-09-571
  28. Alviti F, Agostini F, Conte V, Bernetti A. Linee guida ed evidenze scientifiche sulla terapia infiltrativa intra-articolare in medicina riabilitativa. In: Santilli V, ed. Linee guida ed evidenze scientifiche in Medicina Fisica e Riabilitativa. Rome: Sapienza University of Rome, 2017. Available at: https://snlg.iss.it/wp-content/uploads/2017/11/Santilli_Vol_LineeGuida_MFR_parte-3.pdf. Accessed: 05.08.2022 (in Italian).
  29. Migliore A, Bizzi E, Herrero-Beaumont J, et al. The discrepancy between recommendations and clinical practice for viscosupplementation in osteoarthritis: mind the gap! Eur Rev Med Pharmacol Sci. 2015;19(7):1124-9.
  30. Maheu E, Bannuru RR, Herrero-Beaumont G, et al. Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: results of an extensive critical literature review. Semin Arthritis Rheum. 2019;48(4):563-72. doi: 10.1016/j.semarthrit.2018.06.002
  31. De Lucia O, Pierannunzii LM, Pregnolato F, et al. Effectiveness and Tolerability of Repeated Courses of Viscosupplementation in Symptomatic Hip Osteoarthritis: A Retrospective Observational Cohort Study of High Molecular Weight vs. Medium Molecular Weight Hyaluronic Acid vs. No Viscosupplementation. Front Pharmacol. 2019;10:1007. doi: 10.3389/fphar.2019.01007
  32. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52(11):817-22. doi: 10.1136/ard.52.11.817
  33. Peck J, Slovek A, Miro P, et al. A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee. Orthop Rev (Pavia). 2021;13(2):25549. doi: 10.52965/001c.25549
  34. Richardson C, Plaas A, Block JA. Intra-articular Hyaluronan Therapy for Symptomatic Knee Osteoarthritis. Rheum Dis Clin North Am. 2019;45(3):439-51. doi: 10.1016/j.rdc.2019.04.011
  35. Li Q, Qi X, Zhang Z. Intra-articular oxygen-ozone versus hyaluronic acid in knee osteoarthritis: A meta-analysis of randomized controlled trials. Int J Surg. 2018;58:3-10. doi: 10.1016/j.ijsu.2018.08.007
  36. Concoff A, Sancheti P, Niazi F, et al. The efficacy of multiple versus single hyaluronic acid injections: A systematic review and meta-analysis. BMC Musculoskelet Disord. 2017;18(1):542. doi: 10.1186/s12891-017-1897-2
  37. Беленький А.Г., Денисов Л.Н., Панасюк Е.Ю, и др. Препарат гиалуроновой кислоты «Остенил» для лечения гонартроза. Результаты многоцентрового рандомизированного маскированного годичного исследования. Научно-практическая ревматология. 2005;43(6):49-52 [Belenky AG, Denisov LN, Panasyuk EY, et al. Hyaluronic acid preparation "ostenil" for the treatment of osteoarthritis. Results of multicenter randomized masked a year’s study. Rheumatology Science and Practice. 2005;43(6):49-52 (in Russian)].
  38. Clementi D, D’Ambrosi R, Bertocco P, et al. Efficacy of a single intra-articular injection of ultra-high molecular weight hyaluronic acid for hip osteoarthritis: a randomized controlled study. Eur J Orthop Surg Traumatol. 2018;28(5):915-22. doi: 10.1007/s00590-017-2083-9
  39. Migliore A, Tormenta S, Laganà B, et al. Safety of intra-articular hip injection of hyaluronic acid products by ultrasound guidance: an open study from ANTIAGE register. Eur Rev Med Pharmacol Sci. 2013;17(13):1752-9.
  40. Eymard F, Maillet B, Lellouche H, et al. Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. BMC Musculoskelet Disord. 2017;18(1):3. doi: 10.1186/s12891-016-1359-2
  41. Koyano G, Jinno T, Koga D, et al. Intra-articular Injections of Crosslinked Hyaluronic Acid in Japanese Patients with Symptomatic Osteoarthritis of the Hip. Prog Rehabil Med. 2021;6:20210038. doi: 10.2490/prm.20210038
  42. Fuchs S, Mönikes R, Wohlmeiner A, Heyse T. Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis. Osteoarthritis Cartilage. 2006;14(1):82-8. doi: 10.1016/j.joca.2005.07.016
  43. Riley N, Vella-Baldacchino M, Thurley N, et al. Injection therapy for base of thumb osteoarthritis: a systematic review and meta-analysis. BMJ Open. 2019;9(9):e027507. doi: 10.1136/bmjopen-2018-027507
  44. Monfort J, Rotés-Sala D, Segalés N, et al. Comparative efficacy of intra-articular hyaluronic acid and corticoid injections in osteoarthritis of the first carpometacarpal joint: results of a 6-month single-masked randomized study. Joint Bone Spine. 2015;82(2):116-21. doi: 10.1016/j.jbspin.2014.08.008
  45. Tenti S, Ferretti F, Gusinu R, et al. Impact of thumb osteoarthritis on pain, function, and quality of life: a comparative study between erosive and non-erosive hand osteoarthritis. Clin Rheumatol. 2020;39:2195-206. doi: 10.1007/s10067-020-04982-z
  46. Conrozier T, Monfort J, Chevalier X, et al. EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis. Cartilage. 2020;11(1):47-59. doi: 10.1177/1947603518783455
  47. Migliore A, Gigliucci G, Alekseeva L, et al. Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis. Orthop Res Rev. 2021;13:255-73. doi: 10.2147/ORR.S336185
  48. Abate M, Salini V. Efficacy and safety study on a new compound associating low and high molecular weight hyaluronic acid in the treatment of hip osteoarthritis. Int J Immunopathol Pharmacol. 2017;30(1):89-93. doi: 10.1177/0394632016689275
  49. Callegari L, Spano E, Bini A, et al. Ultrasound-guided injection of a corticosteroid and hyaluronic acid: a potential new approach to the treatment of trigger finger. Drugs R D. 2011;11(2):137-45. doi: 10.2165/11591220-000000000-00000

Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies